A competitive protein binding assay for thyroxine (T-4) and a radioimmunoassay for triiodothyronine (T-3)were applied to determine the urinary concentrations of these hormones.These measurements were shown to offer excellent diagnostic discrimination between euthyroid, hypothyroid, and hyperthyroid subjects. Urinary T-3 and T-4 levels were not affected by changes in the concentration of thyroxine binding globulin (TBG) or by changes in binding capacity; and therefore, remained normal during pregnancy, oestrogen ,and phenytoin therapy. There was no significant circadian variation in urine T-3 excretion. Thus T-3 assays of overnight urine samples could be used in conjunction with dynamic test procedures, such as thyrotrophin (TSH) stimulation test, to enable the rapid assessment of the integrity of the hypothalamic-pituitary-thyroid axis.
Thyroid dysfunction is second only to diabetes mellitus as a cause of endocrine disease and the accurate measurement of thyroid status is, therefore, an important function of the clinical chemistry laboratory. There are, however, two major problems in the laboratory assessment of thyroid function. First, most assays reflect circulating levels of thyroxine (T-4) rather than triiodothyronine (T-3). This is unfortunate, since T-3 is the hormone concerned predominantly with feedback control of the hypothalamic-pituitary-thyroid axis and with the thyroid status of the patient (Schwartz, Surks, and Oppenheimer, 1971 ) and, indeed, it has been suggested that T-4 is merely the prohormone for T-3 (Braverman, Ingbar, and Sterling, 1970; Schwartz et al., 1971) . Second, most assays determine the total amount of thyroid hormone present rather than the relatively minute free fractions, which are thought to be the metabolically active components (Robbins and Rail, 1957; Ingbar and Freinkel, 1963) . Thus the results obtained are influenced by factors that affect either the concentration of thyroid hormone binding proteins (TBP) or their binding capacity (Table 1) as well as by changes in thyroid function (Sisson, 1965; Davies, 1966; Acland, 1958 Acland, , 1971 ). It will be apparent, therefore, that there is an urgent need for a relatively simple technique to assess circulating free T-3 levels.
The recent introduction of highly sensitive and specific radioimmunoassays for serum total T-3 (Ekins, Brown, Ellis, and Reith, 1970; Gharib, Mayberry, and Ryan, 1970; Eastman, Corcoran, Ekins, Williams, and Nabarro, 1972) has helped overcome the first problem. Unfortunately, however, direct techniques for the determination of circulating free hormones, which comprise less than 1 % of the total, are subject to a variety of artefacts (Schussler and P!ager, 1967; Spaulding and Gregerman, 1972) and are too complex and time-consuming for routine application. An excellent indirect means of assessing free T-4 is the calculation of the free thyroxine index (FTl) (Clark and Horn, 1965) or the determination of the effective thyroxine ratio (ETR) (Thorson, Mincey, Mcintosh, and Morrison, 1972) .
As an alternative, we have determined the urinary excretion of T -3 and T -4, based on the assumption that renal glomeruli act as in vivo dialysis units, filtering only non-protein bound hormone and, therefore, that urinary levels relate closely to circulating free hormone concentrations. This approach offers the advantages of measuring both Changes in binding capacity Medication with phenytoin, salicylates or phenylbutazone T-3 and T-4; of assessing thyroid status over a known period, as opposed to serum assays, which assess function only at the time of venepuncture; and of analytical simplicity.
SUBJECfS AND METHODS

Subjects
Several groups of subjects were studied, including 42 healthy, euthyroid volunteer laboratory personnel, medical staff, or medical students, aged 20 to 40. A hospitalised group comprised 50 volunteer inpatients with a variety of medical and surgical conditions, but without clinical or biochemical evidence of renal, hepatic, or endocrine disease. A careful record was made as to whether they had received radiographic contrast media or any drugs known to affect some thyroid function tests. An additional group of 50 euthyroid subjects comprised both in-and out-patients who had been treated for thyroid dysfunction and were subsequently found to be euthyroid, on the basis of clinical and biochemical assessment.
The remaining groups comprised 12 normal, euthyroid women in the third trimester of their pregnancy, and nine women taking oestrogencontaining ovulation inhibitors for more than three months; 30 hospitalised epileptic patients receiving 300-400 mg of phenytoin daily; and 41 hyperthyroid and 32 hypothyroid patients in whom the diagnosis was based primarily on their clinical status, and confirmed by at least two independent thyroid function tests. Thus, in all the subjects studied, serum total T-4 levels were determined using the Thyopac-4 kit (Radiochemical Centre, Amersham) and thyroid hormone uptake measured by the Thyopac-3 (Radiochemical Centre, Amersham), and from these results, FfI was calculated (Clark and Horn, 1965) . In addition, the classification of patients into hypothyroid and hyperthyroid categories was aided by the determination of basal serum thyrotrophin (TSH) levels by radioimmunoassay and measurement of TSH response to a single intravenous dose of thyrotrophin-releasing hormone (TRH) (Ormston, Garry, Cryer, Besser, and Hall, 1971) . Confirmation of T-3 toxicosis was based on the clinical hyperthyroid state of the patient, high serum total T-3, and failure to respond to TRH. In this manner, it was possible to classify all the subjects according to their thyroid status, and the results of all the subjects studied in this survey were included.
Methods
A 12 ml-blood sample was taken from each subject and the serum separated and stored at -20°C until 121 being unfrozen immediately before the determination of total T-3, T-4, TSH, and thyroid hormone uptake. Urine was collected from each subject over a 24-h period, and from one individual over four consecutive days. Urinary T-4 assay. As described previously , duplicate 3 ml aliquots of urine were extracted with ethyl acetate to remove any non-specific substances which may affect the assay, and to concentrate the amount of thyroid hormone. Various solvents were studied and ethyl acetate chosen since it gave the best recovery (85 %, using tracer amounts of added 125I-T-4) and since evaporation of the solvent extract could be accelerated by heating in a waterbath at 50°, without causing significant in vitro conversion of T-4 to T-3. As T-4 is highly soluble in urine at alkaline pH, all samples were acidified to pH4, or lower, by addition of dilute hydrochloric acid prior to extraction (table 2) . Initially, the urine extract was assayed by a competitive protein binding procedure using an anion exchange resin to separate the bound and free fractions. This was later changed to a simpler procedure based on gel equilibration in which 500~I of urine extract were equilibrated for 20 min. in reaction vials containing 0.5 ng of 125I_T_4, 20~I of normal human serum (as binding reagent), 6 ml of barbital buffer (0.06 M, pH 8.6) and 1 g of gel (Sephadex G25, coarse). After mixing, 1 ml of supernatant, containing protein-bound 125I_T_4, was counted, and the counts obtained compared with those found in supernatant from similar vials equilibrated with known amounts of non-radioactive 1'-4 standards. This system has now been adopted by the Radiochemical Centre as the basis of their Thyopac-4 kit. Doubling dilutions of urine extract produce inhibition curves parallel to that caused by serial dilutions of unlabelled standard 1'-4. Further identification was made using thin layer chromatography of the urine extract in a solvent system comprising methyl acetate/isopropanol/5 M ammonium hydroxide (25/35/20 v/v). Urinary T-3 assay. Initially the extraction procedure for urine 1'-4 was modified to enable the parallel determination of 1'-3 by radioimmunoassay (Chan, Besser, Landon, and Ekins, 1972) . Recently, using a more specific antiserum and high activity 125 1_1'_3 (Radiochemical Centre, Amersham), it has been possible to measure 1'-3 in urine directly, without extraction.
Specific anti-1'-3-sera were raised in goats by multiple subcutaneous injections of small amounts of a T-3-bovine serum albumin conjugate. Antisera harvested eight weeks after primary immunisation were usable at titres of 1/30,000 or greater, and showed cross-reactivity of less than 0.02 % with highly purified 1'-4 ( fig. 1 ).
Details of liquid phase T-3 radioimmunoassay
Equals volumes (200 Ill) of urine and barbital buffer (0.06 M, pH 8.6) were incubated with 125 1_1'_3 (15 pg/loo Ill) and anti-T-3-serum (final dilution of 1/30,(00) for 4 h at 4°C. The antibody bound and free fractions were separated by addition of 400 III of a charcoal suspension (2 mg Charcoal Norit OL in 400 III of barbital buffer) to each tube, thorough mixing, centrifugation at 3000 rpm for 10 min, and aspiration of the supernatant. The radioactivity due to the free fraction adsorbed onto the charcoal residue was counted. Duplicate series of aqueous 1'-3 standards were run with each assay and 1'-3 content of the unknown samples read from this curve.
Details of solid phase T-3 radioimmunosorbent technique
A more novel approach was the use of antibody coupled to a solid phase. The coupling procedure described by Wide (1969) was used. Sepharose was first activated by treatment with cyanogen bromide at pH 10.5 and the activated polymer then combined with amino groups on the antibodies in a neutral or The tubes were stoppered, the tube rack attached to a Matburn mixer, and rotated for 4 h at room temperature. After incubation, the tubes were centrifuged at 3000 rpm for 5 min., the plastic caps carefully removed, and the tubes recentrifuged for 2 min. The supernatant was then aspirated, such that approximately 0.3 ml was retained, to prevent disturbing the irnmunosorbent at the bottom of the tube. Using an automatic dispenser, 1 ml of saline was added, the tubes centrifuged for 2 min., and the supernatant removed as before. This wash cycle was repeated once more, and the tubes were then stoppered and counted.
Duplicate series of standards containing 40-1280 pg T-3 per tube were run with each assay and the radioactivity in the standard tubes was expressed as a ratio of that in control tubes containing no un- labelled T-3. This ratio (Bi/Bo) was plotted against the logarithm of the T-3 concentration, and the T-3 values of the unknown samples were read from this curve and expressed as /lg/24 h, based on the total urine volume. Calibration curves using T-3 standards dissolved in T-3-free urine or in buffer were superimposable. This is in agreement with the finding that the addition of even 25 mg of urea to an assay tube had no effect on the T-3-antibody binding reaction. The large amount of diluent buffer used eliminates any pH change due to the urine sample.
RESULTS
Recoveries of added T-3 and T-4 were 98 and 96 %respectively. Assay precision was studied by ten analyses of aliquots of three different urine collections on the same and on five different days. The urines were obtained from hypothyroid, euthyroid, and hyperthyroid subjects respectively. Similar reproducibilities were obtained for the three samples, the mean coefficient of variation for 'within' and 'between' assay precision are shown in Table 4 , and the values are significantly better (p < 0.(01) than those obtained for a serum T-4 assay.
Correlation of T-3 values determined using extracted and unextracted urine
Extraction had no effect on the results of urinary T-3 assays in a random group of 65 patients, measured with and without the solvent extraction step (Fig. 2) . Thus results correlate closely (r = 0.943) for all values in the low, normal, or toxic range.
Correlation of urinary T-3 levels obtained using two different antisera
The T-3 levels in 100 urine samples were determined using two different antisera. Much lower results were obtained when the more specific antiserum B was employed (Fig. 3) , with normal values lying in the range 0.8-2.4 j.1g/24 h as compared with a range of 2.0-4.5 j.1g/24 h with antiserum A.
Urine 24 h values (a) In relation to thyroid function. The urine T-4 concentration in various groups of subjects is presented in fig. 4 . Values in euthyroid subjects range from 4.3-12.7 j.1g/24 h and there is good discrimination between hypothyroid, euthyroid, and hyperthyroid groups, except for 10 thyrotoxic patients whose urinary T-4 level lie close to, or within the upper limit of normal.
Urine T-3 values in the same groups of subjects are shown in Fig. 5 . Normal values lie between 0.8 and 2.4 j.1g/24 h; all hypothyroid patients have low levels (0.02---0.7 j.1g/24 h), while all thyrotoxic patients have raised values (4.0-10.0 j.1gJ24 h). including the 10 with normal or near normal urinary T-4 excretion. A diagnosis of T -3 thyrotoxicosis was subsequently made in each of these patients according to the criteria of Hollander and Shenkman (1972) . In all cases, increased urinary T-3 level preceded that of T-4 by several weeks. Urinary T-4 levels are expressed as~/24 h. 
Application of urinary thyroid hormone assays to dynamic test procedures
As there is no significant circadian variation in urinary T-3 excretion, overnight urine samples were used in conjunction with dynamic tests. 12 excretion were studied in 15 healthy euthyroid subjects (seven men and eight women), including one individual over four consecutive days. Urine collections were made at two-hourly intervals during the day and at four-hourly intervals at night. All samples were run in one assay to avoid inter-assay variability. Individual results will be reported in detail at a later date, but fig. 8 represents a typical excretion pattern obtained over a four-day period.
The T-4 excretion was characterised by minimum levels at night, a rapid rise in the morning, and relatively constant values throughout the day. In contrast, urinary T-3 levels remained constant throughout the study (within 0.4 ng per min. of the mean). (c) In relation to changes in TBP binding. Phenytoin is known to compete with and displace thyroid hormones from TBP. Its effects on thyroid function tests were studied in a group of 30 epileptic patients (receiving 300--400 rng phenytoin daily) and compared with the results of 20 healthy euthyroid subjects and 20 hospitalised patients. Similar urinary T-3 and T-4levels were found in the groups, whereas significantly lower (p<O.OOl) serum total T-4 values were obtained in those receiving the drug ( fig. 7) . (1) Thyroid-stimulating hormone (TSH) test. A single intramuscular injection of 10 IV of TSH gave a maximal urinary T-3 response within 12-20 h, detectable in the first overnight urine specimen after TSH. In eight euthyroid subjects studied, urine T-3 levels increased by 80-140%, to within the thyrotoxic range (table 5) . Five patients with primary hypothyroidism showed little or no response, while two hypopituitary patients had responses intermediate between the two groups.
(2) Thyrotrophin-releasing hormone (TRH) test. Failure to respond to TRH is one of the best indicators of hyperthyroidism. Preliminary experiments, in normal subjects, showed that an oral dose of 40 mg of TRH causes a marked rise in urine T-3, between 140 and 380 % of the basal level. No data is yet available for patients with thyrotoxicosis.
Disadvantages
(1) It is notoriously difficult to collect accurate 24-h urine. This may be avoided by the use of random, timed urine collections and the assay of T-3, the results being expressed as hormone excretion per unit time. Errors due to incomplete 24-h urine collections may also be avoided by the simultaneous measurement of urinary creatinine and expression of T-3 and T-4 results per g of creatinine.
(2) The ethyl acetate extraction step is tedious and time-consuming, and the initial acidification may cause hydrolysis of conjugates and an increase in assayable T-4 (Burke, Shakespeare, and Fraser 1972; Black, Griffiths, Hoffenburg, and Leatherdale, 1973) . The use of highly specific and avid antisera eliminates the need for an extraction step. We have now raised suitable antisera against T-3 in goats, and an extensive immunisation schedule using a highly purified T-4-BSA conjugate is currently being undertaken.
(3) Absolute T-3 values are dependent on the specificity of the antiserum used and it is, therefore, necessary for individual laboratories to determine their own normal range or to use a common antiserum throughout the country.
(4) In the presence of proteinuria, spuriously elevated levels of urinary T-3 and T-4 are obtained (values in excess of 25 ).1g/24 hand 40 ).1g/24 h for T-3 and T-4 respectively have been recorded), due to the excretion of protein-bound as well as free hormone. Results are also invalidated in patients with acute or chronic renal failure, who have reduced glomerular filtration. 
Advantages
(1) Urinary measurements offer excellent diagnostic discrimination between hypothyroid, euthyroid, and hyperthyroid subjects.
(2) Urinary T-3 assays are of particular value in the diagnosis of T-3 toxicosis.
(3) The determination of T-3 in overnight urine samples can be used in conjunction with dynamic procedures, such as TRH and TSH tests, to enable the rapid assessment of the integrity of the hypothalamic-pituitary-thyroid axis. This approach avoids the administration of radioiodine and other disadvantages inherent in tracer studies.
(4) Urinary assays have the advantage of assessing thyroid status over a period of time, and avoid the pain and trauma of venepuncture.
(5) Results are not influenced by changes in TBP concentration or, once equilibrium is established, by drugs that affect binding such as phenytoin and salicylate (Chan, Besser, and Landon, 1973) .
(6) Urinary measurements are capable of reflecting acute changes in thyroid function in certain situations (on initiation of phenytoin or salicylate therapy and following oestrogen withdrawal) that are not measurable by conventional serum thyroid function tests ).
(7) It is easier technically to assay urine than serum samples because of the absence of endogenous TBP. Thus T-3 can be estimated in urine directly without addition of an inhibitor, such as 8-anilinol-naphthalene sulphonic acid, while the use of such compounds are essential with serum assays.
(8) More than 100 urine samples can be assayed with comparative ease in 6 h. CONCLUSION A good clinical test must be judged in terms of its high diagnostic discriminatory power and the rapidity, simplicity and precision of the assay procedure. The urine T-3 assay appears to fulfil these requirements.
